|
Research and Markets: A Guide to the Emerging Global Market in Next
Generation Sequencing for Life Science R&D: Advancing to the $1,000
Genome
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:21072008
Dublin - Research and Markets
(http://www.researchandmarkets.com/research/014440/next_generation_se)
has announced the addition of the "Next Generation Sequencing for Life
Science R&D: Advancing to the $1,000 Genome." report to their offering.
This report examines the emerging, fast-growing worldwide market for
next-generation genome sequencing systems and services. The makers of
the new sequencing systems are competing in the race to drive down the
cost of sequencing a human genome to $1,000 or less. At that cost, life
scientists will be able sequence human genomes at the massive scale
needed to better understand human variation and help open the gateway
to personalized medicine.
The first wave of the commercial high-throughput genome sequencers has
seen a rapid uptake from life science research customers at genome
centers and research service providers from North America, Europe and
Asia. This study looks at the basic technologies that these new DNA
sequencers use and what kinds of applications and research projects
that the scientists are doing.
The new platforms can help accelerate the research capabilities of
basic academic medical research, pharmaceutical and biotech drug
discovery and diagnostic developments. The report also studies the
research service providers that outsource to pharma and biotech
companies because the technologies might help them become more
productive faster.
This report is for business executives, entrepreneurs, venture
capitalists, investors, product managers, research managers, business
development managers, and other decision makers. The next-generation
genome sequencing products and services discussed include technologies
from Illumina, Roche/ 454, Applied Biosystems, Danaher Motion, Helicos
Biosciences, Pacific Biosciences and others.
This study discusses its interesting topics with key findings. The new
data presented estimates that the total next-generation genome
sequencing market size will reach $484 million in 2008 and grow at a
high rate. It reviews the activities of 18 companies. The report uses
38+ figures and tables to illustrate the findings. The study features
convenient tables that help the reader scan the details of key trends,
market segmentation, forecasts, M&As, alliances, grant funding, patents
and the like.
Key Topics Covered:
-Overview of the Genome Sequencing Market for R&D
-Next-Gen. Genome Sequencing Technology Developments
-Key Alliances, M&As and IP
-The Market and Outlook for Next-Generation Genome Sequencing
-Activities of the Firms Offering Next-Generation Genome Sequencing
Products & Services
-Conclusions and New Business Opportunities
For more information visit
http://www.researchandmarkets.com/research/014440/next_generation_se
CONTACT: Laura Wood, Senior Manager, Research and Markets
Fax: +1 646 607 1907 (US)
Fax: +353 1 481 1716 (Rest of World)
e-mail: press@researchandmarkets.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|